1-5 of 5
Emmanuel Olivier
Close
Sort by
Journal Articles

N/KRAS -Mutant AML LSCs Originate from Committed Myelomonocytic Progenitors and Drive Clinical Resistance to Venetoclax

Junya Sango, Saul Carcamo, Nataly Cruz-Rodriguez, Maria Sirenko, Abhishek Maiti, Malgorzata Olszewska, Tiansu Wang, Gulay Bengu Ulukaya, Lewis Tomalin, Emmanuel Olivier, Manon Jaud, Ronan Chaligne, Hager Mansour, Deniz Demircioglu, Dan A. Landau, Elli Papaemmanuil, Courtney D. DiNardo, Dan Hasson, Marina Y. Konopleva, Eirini Papapetrou
Journal: Blood
Blood (2023) 142 (Supplement 1): 403.
https://doi.org/10.1182/blood-2023-187695
Published: 2023
Journal Articles

Proof-of-Concept in a Murine Model of Treatment of Thrombotic Thrombocytopenic Purpura Using Engineered Red Blood Cells Expressing Fragments of ADAMTS13 on Their Membrane

Karl Roberts, Zi Yan, Shouping Zhang, Emmanuel Olivier, Khulan Batbayar, Eric E Bouhassira
Journal: Blood
Blood (2023) 142 (Supplement 1): 1265.
https://doi.org/10.1182/blood-2023-189601
Published: 2023
Journal Articles

iPSC-Derived KitD816V/Jak2V817F Double-Mutant Kitjak Cell Lines Allow Inexpensive Large-Scale Production of Enucleated Red Blood Cells in the Absence of SCF and Erythropoietin

Emmanuel Olivier, Zi Yan, Shouping Zhang, Eric E Bouhassira
Journal: Blood
Blood (2023) 142 (Supplement 1): 2449.
https://doi.org/10.1182/blood-2023-185109
Published: 2023
Journal Articles

Cytokine Independent Production of Enucleated Red Blood Cells from Induced Pluripotent Stem Cells

Emmanuel Olivier, Zi Yan, Eric E. Bouhassira
Journal: Blood
Blood (2022) 140 (Supplement 1): 8150–8151.
https://doi.org/10.1182/blood-2022-166497
Published: 2022
Journal Articles

Adamts13-Cultured Red Blood Cells to Treat Thrombotic Thrombocytopenic Purpura

Kai Wang, PhD, Khulan Batbayar, PhD, Karl Roberts, Emmanuel Olivier, PhD, Eric E. Bouhassira, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 89.
https://doi.org/10.1182/blood-2019-131929
Published: 2019